Zai Lab Limited
ZLAB
$25.34
-$0.07-0.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 449.61M | 453.28M | 460.16M | 441.63M | 427.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 449.61M | 453.28M | 460.16M | 441.63M | 427.80M |
| Cost of Revenue | 432.63M | 416.54M | 411.99M | 382.36M | 390.45M |
| Gross Profit | 16.99M | 36.75M | 48.17M | 59.27M | 37.35M |
| SG&A Expenses | 281.09M | 279.25M | 277.61M | 287.18M | 284.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 713.72M | 695.79M | 689.59M | 669.55M | 674.75M |
| Operating Income | -264.10M | -242.51M | -229.43M | -227.92M | -246.95M |
| Income Before Tax | -190.72M | -179.60M | -178.46M | -206.81M | -212.52M |
| Income Tax Expenses | -2.51M | -1.49M | -2.93M | -- | -- |
| Earnings from Continuing Operations | -188.21 | -178.12 | -175.54 | -206.81 | -212.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -188.21M | -178.12M | -175.54M | -206.81M | -212.52M |
| EBIT | -264.10M | -242.51M | -229.43M | -227.92M | -246.95M |
| EBITDA | -248.17M | -227.01M | -214.42M | -213.79M | -233.85M |
| EPS Basic | -16.98 | -16.16 | -16.03 | -19.43 | -20.41 |
| Normalized Basic EPS | -1.08 | -1.02 | -1.01 | -1.20 | -1.26 |
| EPS Diluted | -16.98 | -16.16 | -16.03 | -19.43 | -20.41 |
| Normalized Diluted EPS | -1.08 | -1.02 | -1.01 | -1.20 | -1.26 |
| Average Basic Shares Outstanding | 443.25M | 440.75M | 438.09M | 430.16M | 418.13M |
| Average Diluted Shares Outstanding | 44.32M | 44.07M | 43.81M | 43.02M | 41.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |